These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 22833355

  • 1. CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.
    Loghavi S, Walts AE, Bose S.
    Diagn Cytopathol; 2013 Jul; 41(7):582-7. PubMed ID: 22833355
    [Abstract] [Full Text] [Related]

  • 2. Improved abnormal Pap smear triage using cervical cancer biomarkers.
    Killeen JL, Dye T, Grace C, Hiraoka M.
    J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
    [Abstract] [Full Text] [Related]

  • 3. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.
    Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, PALMS Study Group.
    Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096
    [Abstract] [Full Text] [Related]

  • 4. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [Abstract] [Full Text] [Related]

  • 5. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y, Zhao J, Hu J, Wu XW, Zhu LR.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):734-739. PubMed ID: 29179267
    [Abstract] [Full Text] [Related]

  • 6. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
    Aromseree S, Wongjumpa W, Ekalaksananan T, Temtanakitpaisan A, Kleebkaow P, Srisathaporn S, Tongchai P, Pientong C.
    Asian Pac J Cancer Prev; 2022 Oct 01; 23(10):3405-3411. PubMed ID: 36308365
    [Abstract] [Full Text] [Related]

  • 7. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
    Pirtea L, Secosan C, Margan M, Moleriu L, Balint O, Grigoras D, Sas I, Horhat F, Jianu A, Ilina R.
    Bosn J Basic Med Sci; 2019 Nov 08; 19(4):336-341. PubMed ID: 29924960
    [Abstract] [Full Text] [Related]

  • 8. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
    Koo YJ, Hahn HS, Lee IH, Lim KT, Lee KH, Kim HS, Kim TJ, Chun YK, Kim HS, Hong SR.
    Virchows Arch; 2013 Nov 08; 463(5):689-96. PubMed ID: 24081504
    [Abstract] [Full Text] [Related]

  • 9. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, Ridder R.
    Gynecol Oncol; 2017 Jan 08; 144(1):51-56. PubMed ID: 28094038
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY, Lim KL, Hilmy MH, Thike AA, Goh ST, Song LH, Hwang JSG, Mantoo S.
    Malays J Pathol; 2017 Dec 08; 39(3):257-265. PubMed ID: 29279588
    [Abstract] [Full Text] [Related]

  • 11. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Franco EL, STAIN-IT Study Group.
    Int J Cancer; 2021 Jan 15; 148(2):492-501. PubMed ID: 32781481
    [Abstract] [Full Text] [Related]

  • 12. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
    Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M.
    Clin Cancer Res; 2012 Aug 01; 18(15):4154-62. PubMed ID: 22675168
    [Abstract] [Full Text] [Related]

  • 13. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C, Bakhiet S, Bates M, Keegan H, Pilkington L, Ruttle C, Sharp L, O' Toole S, Fitzpatrick M, Flannelly G, O' Leary JJ, Martin CM.
    Cytopathology; 2016 Aug 01; 27(4):269-76. PubMed ID: 26932360
    [Abstract] [Full Text] [Related]

  • 14. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 15. p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.
    Schmidt D, Bergeron C, Denton KJ, Ridder R, European CINtec Cytology Study Group.
    Cancer Cytopathol; 2011 Jun 25; 119(3):158-66. PubMed ID: 21442767
    [Abstract] [Full Text] [Related]

  • 16. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 25; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion.
    Waldstrøm M, Christensen RK, Ørnskov D.
    Cancer Cytopathol; 2013 Mar 25; 121(3):136-45. PubMed ID: 22987560
    [Abstract] [Full Text] [Related]

  • 18. Value of P16 expression in the triage of liquid-based cervical cytology with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
    Ma YY, Cheng XD, Zhou CY, Qiu LQ, Chen XD, Lü WG, Xie X.
    Chin Med J (Engl); 2011 Aug 25; 124(16):2443-7. PubMed ID: 21933584
    [Abstract] [Full Text] [Related]

  • 19. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
    Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, Roth P, Lorincz AT, Gafni A.
    CMAJ; 2000 Sep 19; 163(6):701-7. PubMed ID: 11022584
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.
    Ebisch RM, van der Horst J, Hermsen M, Rijstenberg LL, Vedder JE, Bulten J, Bosgraaf RP, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Massuger LF, Melchers WJ, Bekkers RL, Siebers AG.
    Mod Pathol; 2017 Jul 19; 30(7):1021-1031. PubMed ID: 28304400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.